Items where Author is "Viollet, B"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Number of items: 6.

Jeyabalan, J and Viollet, B and Smitham, P and Ellis, S A and Zaman, G and Bardin, C and Goodship, A and Roux, J P and Pierre, M and Chenu, C (2013) The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing. OSTEOPOROSIS INTERNATIONAL, 24 (10). p. 2659.

Jeyabalan, J and Shah, M and Viollet, B and Chenu, C (2012) AMP-activated protein kinase pathway and bone metabolism. JOURNAL OF ENDOCRINOLOGY, 212 (3). pp. 277-290.

Jeyabalan, J and Viollet, B and Smitham, P and Undre, Y and Ellis, S A and Goodship, A and Chenu, C (2012) THE ANTI-DIABETIC DRUG METFORMIN HAS NO DELETERIOUS EFFECT ON BONE MASS IN VIVO BUT DOES NOT INDUCE OSTEOGENESIS NOR FRACTURE HEALING. In: UNSPECIFIED.

Jeyabalan, J and Shah, M and Viollet, B and Roux, J P and Chavassieux, P and Korbonits, M and Chenu, C (2012) Mice lacking AMP-activated protein kinase alpha 1 catalytic subunit have increased bone remodeling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment. JOURNAL OF ENDOCRINOLOGY, 214 (3). pp. 349-358.

Shah, M and Viollet, B and Korbonits, M and Chenu, C (2011) DELETION OF AMP-ACTIVATED PROTEIN KINASE (AMPK)-ALPHA 1 CATALYTIC SUBUNIT IN MICE IMPAIRS THE IN VIVO RESPONSE OF BONES TO HORMONAL CHALLENGES. In: UNSPECIFIED.

Shah, M and Kola, B and Bataveljic, A and Arnett, T R and Viollet, B and Saxon, L and Korbonits, M and Chenu, C (2010) AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. BONE, 47 (2). pp. 309-319.

This list was generated on Wed Oct 27 07:42:28 2021 BST.